Resistance to newly approved and investigational protease inhibitors

Andrea De Luca

doi:10.1097/COH.0b013e3280287a38

Resistance to newly approved and investigational protease inhibitors

Andrea De Luca

Università Cattolica del Sacro Cuore

Risultato della ricerca: Contributo in rivista › Articolo in rivista

4 Citazioni (Scopus)

Abstract

The aim of this paper was to review recent literature on the HIV-1 genotypic and phenotypic resistance determinants of therapeutic response to newly approved protease inhibitors and the viral resistance pathways to these and to investigational protease inhibitors.

Lingua originale	English
pagine (da-a)	130-136
Numero di pagine	7
Rivista	Current Opinion in HIV and AIDS
Volume	2
DOI	https://doi.org/10.1097/COH.0b013e3280287a38
Stato di pubblicazione	Pubblicato - 2007

Keywords

HIV protease inhibitors
resistance

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1097/COH.0b013e3280287a38

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{d8739c5d1caf402aa4cf68be7481fbbc,

title = "Resistance to newly approved and investigational protease inhibitors",

abstract = "The aim of this paper was to review recent literature on the HIV-1 genotypic and phenotypic resistance determinants of therapeutic response to newly approved protease inhibitors and the viral resistance pathways to these and to investigational protease inhibitors.",

keywords = "HIV protease inhibitors, resistance, HIV protease inhibitors, resistance",

author = "{De Luca}, Andrea",

year = "2007",

doi = "10.1097/COH.0b013e3280287a38",

language = "English",

volume = "2",

pages = "130--136",

journal = "Current Opinion in HIV and AIDS",

issn = "1746-630X",

publisher = "Lippincott Williams and Wilkins Ltd.",

}

TY - JOUR

T1 - Resistance to newly approved and investigational protease inhibitors

AU - De Luca, Andrea

PY - 2007

Y1 - 2007

N2 - The aim of this paper was to review recent literature on the HIV-1 genotypic and phenotypic resistance determinants of therapeutic response to newly approved protease inhibitors and the viral resistance pathways to these and to investigational protease inhibitors.

AB - The aim of this paper was to review recent literature on the HIV-1 genotypic and phenotypic resistance determinants of therapeutic response to newly approved protease inhibitors and the viral resistance pathways to these and to investigational protease inhibitors.

KW - HIV protease inhibitors

KW - resistance

KW - HIV protease inhibitors

KW - resistance

UR - http://hdl.handle.net/10807/10562

U2 - 10.1097/COH.0b013e3280287a38

DO - 10.1097/COH.0b013e3280287a38

M3 - Article

SN - 1746-630X

VL - 2

SP - 130

EP - 136

JO - Current Opinion in HIV and AIDS

JF - Current Opinion in HIV and AIDS

ER -

Resistance to newly approved and investigational protease inhibitors

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo